Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: A possible association with intracytoplasmic inclusion body formation

Modern Pathology

Volumn 15, Issue 2, 2002, Pages 146-153

  Shiratsuchi, Hideki ^a   Saito, Tsuyoshi ^a   Sakamoto, Akio ^a   Itakura, Eijun ^a   Tamiya, Sadafumi ^a   Oshiro, Yumi ^a   Oda, Yoshinao ^a   Toh, Satoshi ^a   Komiyama, Sohtaro ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytokeratin 8 (KRT 8); Inclusion body; Malignant rhabdoid tumor; Mutation

Indexed keywords

ARGININE; CYSTEINE; CYTOKERATIN 8; GLUTAMIC ACID; HISTIDINE; ISOLEUCINE; LYSINE; METHIONINE; SERINE; VIMENTIN;

ADULT; ARTICLE; CANCER INVASION; CELL INCLUSION; CHILD; CLINICAL ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; TUMOR CELL;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INFANT; KERATINS; MALE; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; RHABDOID TUMOR; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 18244368252     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880506     Document Type: Article

References (47)

1. Histopathology and prognosis of Wilms tumor. Results from the First National Wilms' tumor study
2. The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence
3. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on comparison between early death and long-term survival
4. Vimentin-positive gastric carcinomas with rhabdoid features. A clinicopathologic and immunohistochemical study
5. Epithelioid sarcoma: An immunohistochemical analysis of 112 classical and variant cases and a discussion of differential diagnosis
6. Rhabdoid feature in leiomyosarcoma of soft tissue: With special reference to aggressive behavior
7. Extraskeletal myxoid chondrosarcoma with rhabdoid features, with special reference to its aggressive behavior
8. Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins
9. Cytokeratin subunits of inclusion bodies in rhabdoid cells: Immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma
10. Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor cells: Three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence
11. The catalog of human cytokeratins: Patterns of expression in normal epithelial, tumors and cultured cells
12. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
13. Epidermolysis bullosa simplex (Dowling-Meara type) is genetic disease characterized by an abnormal keratin filament network involving keratins K5 and K14
14. A leucine → proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis
15. A mutation (Met → Arg) in the type I keratin (K14) gene responsible for autosomal dominant epidermolysis bullosa simplex
16. Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function
17. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex
18. Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex
19. Intermediate filaments and disease: Mutations that cripple cell length
20. Mutations in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis
21. Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE)
22. Analysis of cytokeratin domains by cloning and expression of intact and deleted polypeptides in Escherichia coli
23. Mutations of the p53 gene in malignant rhabdoid tumors of soft part and the kidney: Immunohistochemical and DNA direct sequencing analysis
24. Establishment of rhabdoid tumor cell line with a special chromosomal abnormality, 46, XY, t(11;22)(p15.5;q11.23)
25. Malignant rhabdoid tumor. A study with two established cell lines
26. Narrowing the critical region for a rhabdoid tumor locus in 22q11
27. Establishment and characterization of malignant rhabdoid tumor of the kidney
28. Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry
29. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphogly-cokeratins in transgenic mice expressing a keratin 18 conversed arginine mutant
30. Posttranslational events in griseofulvin-induced keratin cytoskeleton alterations
31. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant
32. Mutation of human keratin 18 in associated with cryptogenic cirrhosis
33. Cloning and sequence of cDNA for human placental cytokeratin 8. Regulation of mRNA in trophoblastic cells by cAMP
34. Organization and sequence of the human gene encoding cytokeratin 8
35. The t(11;22)(p15.5;q11.23) in a retroperitoneal rhabdoid tumor also includes a regional deletion distal to CRYBB2 on 22q
36. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors
37. Cytogenic and molecular analysis of a t(1;22)(p36;11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22
38. Alteration of hSNF5/IN11/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors
39. Truncating mutations of hSNF5/IN11 in aggressive paediatric cancer
40. The conserved H1 domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbor molecules in mouse and human keratin 1/keratin 10 intermediate filaments and the two- to four-molecule level of structure
41. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells
42. A monoclonal antibody epitope on keratin 8 identified using a phage peptide library
43. Keratin intermediate filament structure. Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly
44. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells
45. Keratin 8 phosphorylation in vitro by cAMP-dependent protein kinase occurs within the amino- and carboxyl-terminal end domains
46. Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431
47. Identification of novel and known mutations in the genes for keratin 5 and 14 in Danish patients with epidermolysis bullosa simplex: Correlation between genotype and phenotype